Pricing authority caps rates of key diabetes drugsIndia’s drug pricing authority has fixed prices of two key anti diabetes drugs-Sitagliptin-Metformin combination and Linagliptin-metformin ...
26 Aug, 2022, 09.59 AM IST
NPPA fixes price caps for 12 anti-diabetic medicinesThese include glimepiride tablet of strength 1 mg, with ceiling price at Rs 3.6 per tablet, while that for 2 mg is Rs 5.72 per tablet. The ...
25 Oct, 2021, 05.28 PM IST
Granules gets American drug regulator's nod for diabetes management drug MetforminThe US Food and Drug Administration (USFDA) has granted final approval for the company's abbreviated new drug application (ANDA) for Metfor...
13 Jan, 2021, 12.45 PM IST
Lupin gets USFDA nod for generic diabetes drugThe company has received tentative approval for the product in multiple strengths from the United States Food and Drug Administration (USFD...
07 Jan, 2021, 04.53 PM IST
Alembic Pharma gets tentative nod from USFDA for type-2 diabetes management drugAlembic Pharma said it is currently in litigation with Boehringer Ingelheim in District Court of Delaware and launch of the product will de...
20 Jul, 2020, 11.59 AM IST
Lupin recalls diabetes treatment drug in USDrug major Lupin Ltd on Wednesday said it is voluntarily recalling its diabetes treatment drug Metformin Hydrochloride extended-release tab...
08 Jul, 2020, 11.47 AM IST
Marksans Pharma recalls 11,279 bottles of diabetes drug due to cancer causing chemicalThe company has issued voluntary recall of one batch of Metformin extended release tablets (USP 500 mg) due to detection of NDMA (N-nitroso...
08 Jun, 2020, 03.47 PM IST
Drug pricing regulator fixes prices of 40 formulation drugsThe regulator has reduced the maximum retail price of a new class of drugs, including statins, diabetes drugs, cardiovascular and combinati...
04 Jun, 2020, 08.27 AM IST
Unichem, Macleods Pharma recall drugs from US marketDrug firms Unichem Pharmaceuticals and Macleods Pharma are recalling various lots of tablets used for treatment of high blood pressure and ...
16 Feb, 2020, 01.10 PM IST
Sun Pharma recalls over 2,500 bottles of diabetes drug from USThe reason for recall is presence of foreign substance- one lot of these tablets contains foreign matter identified as a piece of rubber gl...
29 Jul, 2018, 11.21 AM IST
Sun Pharma slips despite USFDA nod for generic diabetes drugAt 12:11 pm, shares of the pharma giant were trading at Rs 836.70 apiece, up 0.19 per cent from its previous close on Bombay Stock Exchange...
02 Aug, 2016, 06.55 PM IST
Marksans Pharma gets USFDA nod for diabetes treatment tabletsThe product is generic version of Bristol Meyers Squibb's Glucophage XR extended release tablets in the same strengths, it added.
02 May, 2016, 03.07 PM IST
Aurobindo Pharma gets USFDA nod for generic Metformin tabletsAurobindo Pharma has received final approval from the USFDA to manufacture and market Metformin Hydrochloride tablets used for treating dia...
23 Jul, 2012, 01.57 PM IST
- Lupin gets USFDA approval for diabetes drug
Lupin today said it has received approval from the US health regulator for its Metformin Hydrochloride Extended Release tablets, used in tr...
30 Jan, 2012, 06.42 PM IST
- Aurobindo Pharma gets Swiss nod for two products
Drug maker Aurobindo Pharma today said Swiss authorities have approved licences for two of its medicines used in treatment of diabetes and ...
07 Sep, 2009, 12.51 PM IST
- Ranbaxy gets USFDA nod for diabetic drug
Drug maker Ranbaxy's wholly-owned US subsidiary receives USFDA approval to market Metformin Hydrochloride tablets.
13 Aug, 2007, 11.35 AM IST
- Aurobindo to market diabetes drug in S Africa
After USA, Aurobindo Pharma is all set to market its diabetes drug Metformin tablets in South Africa, as it has received marketing authoris...
26 Apr, 2007, 06.10 PM IST